Grace Halsey

In persons who received both the HZV and Tdap vaccines, a significant 50% reduction in risk of dementia was seen, suggesting a nonspecific underlying association.

Results of a new study that used early clinical surrogate markers of metabolic disease find women at greater risk related to suboptimal sleep.

The CDC update recommends that clinicians advise all sexually active patients about PrEP and includes a new section on prescribing injectable bimonthly cabotegravir.

Dr Ahmad's book explores in depth the complex long-term consequences of COVID-19 for medicine, mental health, and social conventions.

The highest percentage of youth without a high school diploma is in New Mexico and the youth poverty rate is highest in DC. More red flag indicators follow.

Funds will be used to develop institutional and community programs that target high stress health care work environments, already strained before the pandemic.

Americans with anxiety, depression, and PTSD would be willing to try ketamine, psilocybin, and MDMA if they worked better than traditional medications, a Harris Poll finds.

Glucose and insulin levels decreased after just 3 minutes of the moderate-intensity exercise, a promising finding for those with type 2 diabetes, say authors of a new study.

Coronary heart disease prevalence in the US between 2011 and 2018 saw a statistically insignificant change, from 6.2% to 6.0%, respectively.

Donna Ryan, MD, wishes for universal understanding of obesity as a serious chronic disease, for a start. Her other wishes are equally ambitious.

Use of continuous glucose monitoring to assess time in target glucose range in T2D patients was evaluated in a systematic literature review covering ~14 000 participants.

California on Jan 1 became the first state to require insurance coverage for at-home testing for sexually transmitted infections; it isn't smooth sailing, yet.

VIDEO Interview: The COVID-19 pandemic has closed what discussion remained about the status of obesity as a disease, according to obesity expert Donna Ryan, MD.

WATCH: The FDA approval of semaglutide 2.4 mg for adults with obesity was "by far the big event in 2021," said Donna Ryan, MD. More from our look back/look ahead interview, here.

Using Mendelian randomization, a new study found in particular that waist-hip ratio may be a more important predictor of hospitalization than BMI.

Screening of older adults for falls and cognitive impairment should be routine in primary care; a recent study highlights an intervention that could help.

Seven at-home COVID-19 rapid tests, all available online or at retail, are ranked for dexterity required, instruction legibility, and other features you may need to parse for your patients.

The largest US non-profit patient safety organization evaluated 7 COVID-19 rapid tests and found serious deficiencies in usability; none were rated "excellent."

Click through top flu indicators tracked by the Centers for Disease Control and Prevention weekly US influenza surveillance report.

Herpes zoster vaccination rates in the US have ticked up only minimally since FDA approval of Shingrix. Brush up on the basics of the vaccine and pass it on to your patients.

Digital health products and advanced remote monitoring applications received more attention than ever at CES, driven by rapid evolution in the space during the COVID-19 pandemic.

"COVID-somnia," defined as a group of chronic sleep disturbances, has made adequate rest elusive for millions, including health care first responders.

The ADA's annual update to its comprehensive evidence-based standards includes new guidance on diabetes screening, first-line therapies, and comorbid NAFLD/NASH.

The J&J booster shot given to health care workers in South Africa between mid-Nov and mid-Dec 2021 was highly effective against Omicron infection.

The CDC recommends against the J&J COVID-19 vaccine if Pfizer or Moderna mRNA shots are available while affirming that any COVID vaccine is better than none.

While use of insulin pumps and CGM increased over a 3-year study period for all racial-ethnic groups, the inequities were significant between White adults and all others.

Finerenone, the nonsteroidal mineralocorticoid receptor antagonist, significantly reduced new-onset HF and improved other HF outcomes in the FIGARO-DKD trial.

Pfizer reported today final results of the phase 2/3 EPIC-HR trial, findings that confirm the investigational drug's 89% efficacy against severe COVID-19 disease.

Referencing waning immunity of the 2-dose mRNA series and availability of the vaccine to youth in this age group for more than a year, FDA determined that benefits outweigh risks.

Increases in obesity parameters significantly increased risk of incident heart failure in persons with diabetes, but not without diabetes, in a large community-based cohort study.